The delivery of siRNA into cells poses several challenges. First, siRNA molecules are prone to degradation by nucleases in the bloodstream. Second, siRNA must efficiently cross the cellular membrane to reach the cytoplasm, where it can exert its gene-silencing effects. Lastly, unmodified siRNA can trigger an immune response, leading to inflammation and other side effects.
